Biostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan™ Esophageal Implant for Treatment of Esophageal Conditions

Biostage's technology has the potential to not only avoid multiple complex surgeries, but also improve the patient's quality of life compared to the current standard of care. >>>

Esophageal Atresia:
A Life-Threatening Condition
that Demands Effective Treatment

Approximately 1 in 4,000 babies, in the US alone, are born with this congenital defect. Find out how Biostage is working to answer this unmet medical need. >>>

Cellspan™ Implants:
Signal and Guide Regeneration

Bioengineered implants guide the regeneration of a biological structure. Learn how stem cells adhere to and interact with the implant. >>>